Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Actinium Pharmaceuticals (ATNM) Long-Term Deferred Tax (2021 - 2022)

Actinium Pharmaceuticals (ATNM) has disclosed Long-Term Deferred Tax for 2 consecutive years, with $89000.0 as the latest value for Q4 2022.

  • Quarterly Long-Term Deferred Tax fell 84.16% to $89000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $89000.0 through Dec 2022, down 84.16% year-over-year, with the annual reading at $89000.0 for FY2022, 84.16% down from the prior year.
  • Long-Term Deferred Tax for Q4 2022 was $89000.0 at Actinium Pharmaceuticals, down from $562000.0 in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $562000.0 in Q4 2021, with the low at $89000.0 in Q4 2022.